Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sphere of biopharmaceuticals, presenting promising progress across various clinical and industrial applications. With its structural similarity to naturally derived human serum albumin, OsrHSA delivers a safer, more reputable substitute for therapeutic use, significantl